These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 18238884

  • 1. Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan.
    Kirikae T, Mizuguchi Y, Arakawa Y.
    J Antimicrob Chemother; 2008 Mar; 61(3):612-5. PubMed ID: 18238884
    [Abstract] [Full Text] [Related]

  • 2. [Multidrug-resistant Pseudomonas aeruginosa T].
    Kirikae T.
    Nihon Rinsho; 2012 Feb; 70(2):231-5. PubMed ID: 22413523
    [Abstract] [Full Text] [Related]

  • 3. Investigation of beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea.
    Suk SE, Yoo JS, Lee JK, Lee KM, Chung GT, Shin ES, Han SY, Lee SH, Kim J, Lee YS.
    J Microbiol Biotechnol; 2007 Oct; 17(10):1733-7. PubMed ID: 18156795
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II.
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [Abstract] [Full Text] [Related]

  • 9. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
    Dong F, Xu XW, Song WQ, Lü P, Yu SJ, Yang YH, Shen XZ.
    Chin Med J (Engl); 2008 Sep 05; 121(17):1611-6. PubMed ID: 19024085
    [Abstract] [Full Text] [Related]

  • 10. [Multidrug resistant bacteria in a psychiatric milieu].
    Eveillard M, Manuel C, Gabastou JM, Caer M, Mounier M, Bourlioux P.
    Pathol Biol (Paris); 1999 Dec 05; 47(10):1075-9. PubMed ID: 10674262
    [Abstract] [Full Text] [Related]

  • 11. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.
    Nakamura A, Miyake K, Misawa S, Kuno Y, Horii T, Kondo S, Tabe Y, Ohsaka A.
    J Hosp Infect; 2013 Feb 05; 83(2):153-5. PubMed ID: 23201400
    [Abstract] [Full Text] [Related]

  • 12. Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa.
    Tseng SP, Teng LJ, Chen CT, Lo TH, Hung WC, Chen HJ, Hsueh PR, Tsai JC.
    Lasers Surg Med; 2009 Jul 05; 41(5):391-7. PubMed ID: 19533759
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE, D'Agata EM, Paterson DL, Clarke L, Qureshi ZA, Potoski BA, Peleg AY.
    Transpl Infect Dis; 2009 Jun 05; 11(3):227-34. PubMed ID: 19302282
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
    Abdallah HB, Noomen S, Khélifa AB, Sahnoun O, Elargoubi A, Mastouri M.
    Med Mal Infect; 2008 Oct 05; 38(10):554-6. PubMed ID: 18814981
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital.
    Jayakumar S, Appalaraju B.
    Indian J Pathol Microbiol; 2007 Oct 05; 50(4):922-5. PubMed ID: 18306607
    [Abstract] [Full Text] [Related]

  • 20. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
    Parker CM, Kutsogiannis J, Muscedere J, Cook D, Dodek P, Day AG, Heyland DK, Canadian Critical Care Trials Group.
    J Crit Care; 2008 Mar 05; 23(1):18-26. PubMed ID: 18359417
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.